Canada· CA-DIN-02498405
COSACTHEN
A medicinal product containing tetracosactide, registered in Canada by DECHRA LTD.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- TETRACOSACTIDE
- Manufacturer
- DECHRA LTD
- Country
- Canada (CA)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Tetracosactide in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesCortrosynHenry Schein, Inc.
- United KingdomSynacthen 250micrograms/1ml solution for injection ampoulesAtnahs Pharma UK Ltd
- NorwaySynacthenAlfasigma S.p.A
- FranceSYNACTHENE 0,25 mg/1 ml, solution injectableALFASIGMA (ITALIE)
- NetherlandsSynacthen 0,25 mg/ml, oplossing voor injectie of infusieAlfasigma S.p.A.
- SwedenSynacthen 0,25 mg/ml Injektions-/infusionsvätska, lösningAlfasigma S.P.A.
- Japanテトラコサクチド酢酸塩アルフレッサファーマ
- SwitzerlandSynacthen, InjektionslösungAtnahs Pharma Switzerland AG
Authorised across Europe · EMA
The same active substance is authorised in 9 EEA countries. Names it is sold under:
- Austria · Synacthen Ampulle, Synacthen Depot
- Belgium · Synacthen, Synacthen Depot
- Denmark · Synacthen
- France · Synacthene, Synacthene Retard
- Ireland · Synacthen
- Italy · Synacthen
- Luxembourg · Synacthen, Synacthen Dépôt
- Netherlands · Synacthen
- Sweden · Synacthen, Synacthen Depot
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/be951762-2926-4ca6-b7d0-33cd79b4f782 GET /v1/drugs/be951762-2926-4ca6-b7d0-33cd79b4f782?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "02498405",
"form": "SOLUTION",
"class": "Veterinary",
"routes": [
"INTRAVENOUS",
"INTRAMUSCULAR"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": null,
"schedule": [
"Prescription"
],
"drug_code": "98823",
"strengths": [
"0.25 MG"
],
"ahfs_class": null,
"substances": [
"TETRACOSACTIDE"
],
"product_categorization": null
}See everything about tetracosactide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.